Table of Contents Global Bioengineered Protein Drugs Market by Manufacturers, Regions, Type and Application, Forecast to 2023 1 Market Overview 1.1 Bioengineered Protein Drugs Introduction 1.2 Market Analysis by Type 1.2.1 Therapeutic Proteins 1.2.2 Monoclonal Antibodies 1.2.3 Vaccines 1.3 Market Analysis by Applications 1.3.1 Diabetes and Hormonal Disorders 1.3.2 Genetic and Fertility Disorders 1.3.3 Cancers 1.3.4 Organ Transplants 1.3.5 Others 1.4 New Project SWOT Analysis of Bioengineered Protein Drugs 1.5 Industry News Analysis of Bioengineered Protein Drugs 2 Industrial Chain Analysis 2.1 Industry Chain Structure of Bioengineered Protein Drugs 2.2 Raw Material Analysis of Bioengineered Protein Drugs 2.2.1 Raw Material A Market Analysis 2.2.2 Raw Material B Market Analysis 2.2.3 Raw Material C Market Analysis 2.3 Labor Cost Analysis of Bioengineered Protein Drugs 2.4 Other Costs Analysis of Bioengineered Protein Drugs 2.5 Manufacturing Cost Structure Analysis of Bioengineered Protein Drugs 2.6 Manufacturing Process Analysis of Bioengineered Protein Drugs 2.7 Raw Materials Sources of Bioengineered Protein Drugs Major Manufacturers in 2017 2.8 Downstream Buyers of Bioengineered Protein Drugs 3 Global Bioengineered Protein Drugs Players Profiles and Sales Data 3.1 Abbott Laboratories 3.1.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors 3.1.2 Bioengineered Protein Drugs Product Category, Application and Specification 3.1.2.1 Therapeutic Proteins 3.1.2.2 Monoclonal Antibodies 3.1.2.3 Vaccines 3.1.3 Abbott Laboratories Bioengineered Protein Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.1.4 Abbott Laboratories Different Types of Bioengineered Protein Drugs Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) 3.1.5 Abbott Laboratories Bioengineered Protein Drugs Volume in Different Applications and Its Application Share 3.2 F. Hoffmann-La Roche Ltd 3.2.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors 3.2.2 Bioengineered Protein Drugs Product Category, Application and Specification 3.2.2.1 Therapeutic Proteins 3.2.2.2 Monoclonal Antibodies 3.2.2.3 Vaccines 3.2.3 F. Hoffmann-La Roche Ltd Bioengineered Protein Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.2.4 F. Hoffmann-La Roche Ltd Different Types of Bioengineered Protein Drugs Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) 3.2.5 F. Hoffmann-La Roche Ltd Bioengineered Protein Drugs Volume in Different Applications and Its Application Share 3.3 Amgen, Inc. 3.3.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors 3.3.2 Bioengineered Protein Drugs Product Category, Application and Specification 3.3.2.1 Therapeutic Proteins 3.3.2.2 Monoclonal Antibodies 3.3.2.3 Vaccines 3.3.3 Amgen, Inc. Bioengineered Protein Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.3.4 Amgen, Inc. Different Types of Bioengineered Protein Drugs Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) 3.3.5 Amgen, Inc. Bioengineered Protein Drugs Volume in Different Applications and Its Application Share 3.4 Bayer AG 3.4.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors 3.4.2 Bioengineered Protein Drugs Product Category, Application and Specification 3.4.2.1 Therapeutic Proteins 3.4.2.2 Monoclonal Antibodies 3.4.2.3 Vaccines 3.4.3 Bayer AG Bioengineered Protein Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.4.4 Bayer AG Different Types of Bioengineered Protein Drugs Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) 3.4.5 Bayer AG Bioengineered Protein Drugs Volume in Different Applications and Its Application Share 3.5 Merck & Co., Inc. 3.5.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors 3.5.2 Bioengineered Protein Drugs Product Category, Application and Specification 3.5.2.1 Therapeutic Proteins 3.5.2.2 Monoclonal Antibodies 3.5.2.3 Vaccines 3.5.3 Merck & Co., Inc. Bioengineered Protein Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.5.4 Merck & Co., Inc. Different Types of Bioengineered Protein Drugs Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) 3.5.5 Merck & Co., Inc. Bioengineered Protein Drugs Volume in Different Applications and Its Application Share 3.6 Dr. Reddy's Laboratories Ltd. 3.6.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors 3.6.2 Bioengineered Protein Drugs Product Category, Application and Specification 3.6.2.1 Therapeutic Proteins 3.6.2.2 Monoclonal Antibodies 3.6.2.3 Vaccines 3.6.3 Dr. Reddy's Laboratories Ltd. Bioengineered Protein Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.6.4 Dr. Reddy's Laboratories Ltd. Different Types of Bioengineered Protein Drugs Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) 3.6.5 Dr. Reddy's Laboratories Ltd. Bioengineered Protein Drugs Volume in Different Applications and Its Application Share 3.7 Biocon Ltd. 3.7.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors 3.7.2 Bioengineered Protein Drugs Product Category, Application and Specification 3.7.2.1 Therapeutic Proteins 3.7.2.2 Monoclonal Antibodies 3.7.2.3 Vaccines 3.7.3 Biocon Ltd. Bioengineered Protein Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.7.4 Biocon Ltd. Different Types of Bioengineered Protein Drugs Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) 3.7.5 Biocon Ltd. Bioengineered Protein Drugs Volume in Different Applications and Its Application Share 3.8 Eli Lilly and Company 3.8.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors 3.8.2 Bioengineered Protein Drugs Product Category, Application and Specification 3.8.2.1 Therapeutic Proteins 3.8.2.2 Monoclonal Antibodies 3.8.2.3 Vaccines 3.8.3 Eli Lilly and Company Bioengineered Protein Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.8.4 Eli Lilly and Company Different Types of Bioengineered Protein Drugs Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) 3.8.5 Eli Lilly and Company Bioengineered Protein Drugs Volume in Different Applications and Its Application Share 3.9 Sanofi 3.9.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors 3.9.2 Bioengineered Protein Drugs Product Category, Application and Specification 3.9.2.1 Therapeutic Proteins 3.9.2.2 Monoclonal Antibodies 3.9.2.3 Vaccines 3.9.3 Sanofi Bioengineered Protein Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.9.4 Sanofi Different Types of Bioengineered Protein Drugs Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) 3.9.5 Sanofi Bioengineered Protein Drugs Volume in Different Applications and Its Application Share 3.10 GlaxoSmithKline plc 3.10.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors 3.10.2 Bioengineered Protein Drugs Product Category, Application and Specification 3.10.2.1 Therapeutic Proteins 3.10.2.2 Monoclonal Antibodies 3.10.2.3 Vaccines 3.10.3 GlaxoSmithKline plc Bioengineered Protein Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.10.4 GlaxoSmithKline plc Different Types of Bioengineered Protein Drugs Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) 3.10.5 GlaxoSmithKline plc Bioengineered Protein Drugs Volume in Different Applications and Its Application Share 3.11 Johnson & Johnson 3.12 JanssenNovartis AG 3.13 Panacea Biotec 3.14 ProBioGen AG 4 Global Bioengineered Protein Drugs Market Competition by Manufacturers 4.1 Global Bioengineered Protein Drugs Sales and Share by Manufacturers (2012-2017) 4.2 Global Bioengineered Protein Drugs Revenue (Million USD) and Share (%) by Manufacturers (2012-2017) 4.3 Market Concentration Rate 4.3.1 Top 3 Bioengineered Protein Drugs Manufacturer Market Share 4.3.2 Top 6 Bioengineered Protein Drugs Manufacturer Market Share 4.4 Market Competition Trend 5 Global Bioengineered Protein Drugs Market Analysis by Regions 5.1 Global Bioengineered Protein Drugs Sales, Revenue and Market Share by Regions 5.1.1 Global Bioengineered Protein Drugs Sales by Regions (2012-2017) 5.1.2 Global Bioengineered Protein Drugs Revenue by Regions (2012-2017) 5.2 North America Bioengineered Protein Drugs Sales and Growth Rate (2012-2017) 5.3 Europe Bioengineered Protein Drugs Sales and Growth Rate (2012-2017) 5.4 Asia-Pacific Bioengineered Protein Drugs Sales and Growth Rate (2012-2017) 5.5 South America Bioengineered Protein Drugs Sales and Growth Rate (2012-2017) 5.6 Middle East and Africa Bioengineered Protein Drugs Sales and Growth Rate (2012-2017) 6 North America Bioengineered Protein Drugs by Countries 6.1 North America Bioengineered Protein Drugs Sales, Revenue and Market Share by Countries 6.1.1 North America Bioengineered Protein Drugs Sales by Countries (2012-2017) 6.1.2 North America Bioengineered Protein Drugs Revenue by Countries (2012-2017) 6.2 United States Bioengineered Protein Drugs Sales and Growth Rate (2012-2017) 6.3 Canada Bioengineered Protein Drugs Sales and Growth Rate (2012-2017) 6.4 Mexico Bioengineered Protein Drugs Sales and Growth Rate (2012-2017) 7 Europe Bioengineered Protein Drugs by Countries 7.1 North America Bioengineered Protein Drugs Sales, Revenue and Market Share by Countries 7.1.1 Europe Bioengineered Protein Drugs Sales by Countries (2012-2017) 7.1.2 Europe Bioengineered Protein Drugs Sales by Countries (2012-2017) 7.2 Germany Bioengineered Protein Drugs Sales and Growth Rate (2012-2017) 7.3 France Bioengineered Protein Drugs Sales and Growth Rate (2012-2017) 7.4 UK Bioengineered Protein Drugs Sales and Growth Rate (2012-2017) 7.5 Russia Bioengineered Protein Drugs Sales and Growth Rate (2012-2017) 7.6 Italy Bioengineered Protein Drugs Sales and Growth Rate (2012-2017) 8 Asia-Pacific Bioengineered Protein Drugs by Countries 8.1 Asia-Pacific Bioengineered Protein Drugs Sales, Revenue and Market Share by Countries 8.1.1 Asia-Pacific Bioengineered Protein Drugs Sales by Countries (2012-2017) 8.1.2 Asia-Pacific Bioengineered Protein Drugs Sales by Countries (2012-2017) 8.2 China Bioengineered Protein Drugs Sales and Growth Rate (2012-2017) 8.3 Japan Bioengineered Protein Drugs Sales and Growth Rate (2012-2017) 8.4 Korea Bioengineered Protein Drugs Sales and Growth Rate (2012-2017) 8.5 India Bioengineered Protein Drugs Sales and Growth Rate (2012-2017) 8.6 Bioengineered Protein Drugs Sales and Growth Rate (2012-2017) 9 South America Bioengineered Protein Drugs by Countries 9.1 South America Bioengineered Protein Drugs Sales, Revenue and Market Share by Countries 9.1.1 South America Bioengineered Protein Drugs Sales by Countries (2012-2017) 9.1.2 South America Bioengineered Protein Drugs Sales by Countries (2012-2017) 9.2 Brazil Bioengineered Protein Drugs Sales and Growth Rate (2012-2017) 9.3 Argentina Bioengineered Protein Drugs Sales and Growth Rate (2012-2017) 9.4 Columbia Bioengineered Protein Drugs Sales and Growth Rate (2012-2017) 10 Middle East and Africa Bioengineered Protein Drugs by Countries 10.1 Middle East and Africa Bioengineered Protein Drugs Sales, Revenue and Market Share by Countries 10.1.1 Middle East and Africa Bioengineered Protein Drugs Sales by Countries (2012-2017) 10.1.2 Middle East and Africa Bioengineered Protein Drugs Sales by Countries (2012-2017) 10.2 Bioengineered Protein Drugs Sales and Growth Rate (2012-2017) 10.3 UAE Bioengineered Protein Drugs Sales and Growth Rate (2012-2017) 10.4 Egypt Bioengineered Protein Drugs Sales and Growth Rate (2012-2017) 10.5 Nigeria Bioengineered Protein Drugs Sales and Growth Rate (2012-2017) 10.6 South Africa Bioengineered Protein Drugs Sales and Growth Rate (2012-2017) 11 Global Bioengineered Protein Drugs Market Segment by Type 11.1 Global Bioengineered Protein Drugs Sales, Revenue and Market Share by Type (2012-2017) 11.1.1 Global Bioengineered Protein Drugs Sales and Market Share by Type (2012-2017) 11.1.2 Global Bioengineered Protein Drugs Revenue and Market Share by Type (2012-2017) 11.2 Therapeutic Proteins Sales Growth Rate and Price 11.2.1 Global Therapeutic Proteins Sales Growth Rate (2012-2017) 11.2.2 Global Therapeutic Proteins Price (2012-2017) 11.3 Monoclonal Antibodies Sales Growth Rate and Price 11.3.1 Global Monoclonal Antibodies Sales Growth Rate (2012-2017) 11.3.2 Global Monoclonal Antibodies Price (2012-2017) 11.4 Vaccines Sales Growth Rate and Price 11.4.1 Global Vaccines Sales Growth Rate (2012-2017) 11.4.2 Global Vaccines Price (2012-2017) 11.5 Sales Growth Rate and Price 11.5.1 Global Sales Growth Rate (2012-2017) 11.5.2 Global Price (2012-2017) 11.6 Sales Growth Rate and Price 11.6.1 Global Sales Growth Rate (2012-2017) 11.6.2 Global Price (2012-2017) 12 Global Bioengineered Protein Drugs by Application 12.1 Global Bioengineered Protein Drugs Sales Market Share by Application (2012-2017) 12.2 Diabetes and Hormonal Disorders Sales Growth Rate (2012-2017) 12.3 Genetic and Fertility Disorders Sales Growth Rate (2012-2017) 12.4 Cancers Sales Growth Rate (2012-2017) 12.5 Organ Transplants Sales Growth Rate (2012-2017) 12.6 Others Sales Growth Rate (2012-2017) 13 Global Bioengineered Protein Drugs Market Forecast (2018-2023) 13.1 Global Bioengineered Protein Drugs Sales Volume, Revenue and Price Forecast (2018-2023) 13.1.1 Global Bioengineered Protein Drugs Sales Volume and Growth Rate Forecast (2018-2023) 13.1.2 Global Bioengineered Protein Drugs Revenue and Growth Rate Forecast (2018-2023) 13.1.3 Global Bioengineered Protein Drugs Price and Trend Forecast (2018-2023) 13.2 Global Bioengineered Protein Drugs Sales Volume, Revenue and Growth Rate Forecast by Region (2018-2023) 13.2.1 Global Bioengineered Protein Drugs Sales Volume and Growth Rate Forecast by Regions (2018-2023) 13.2.2 Global Bioengineered Protein Drugs Revenue and Growth Rate Forecast by Regions (2018-2023) 13.2.3 Global Bioengineered Protein Drugs market competition by top manufacturers, with production, price, revenue (value) and market share for each manufacturer; the top players including Bioengineered Protein Drugs Sales Volume, Revenue and Growth Rate Forecast (2018-2023) 13.2.4 North America (United States, Canada and Mexico) Bioengineered Protein Drugs Sales Volume, Revenue and Growth Rate Forecast (2018-2023) 13.2.5 Europe (Germany, France, UK, Russia and Italy) Bioengineered Protein Drugs Sales Volume, Revenue and Growth Rate Forecast (2018-2023) 13.2.6 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Bioengineered Protein Drugs Sales Volume, Revenue and Growth Rate Forecast (2018-2023) 13.2.7 South America (Brazil, Argentina, Columbia) Bioengineered Protein Drugs Sales Volume, Revenue and Growth Rate Forecast (2018-2023) 13.2.8 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Bioengineered Protein Drugs Sales Volume, Revenue and Growth Rate Forecast (2018-2023) 13.3 Global Bioengineered Protein Drugs Sales Volume, Revenue and Price Forecast by Type (2018-2023) 13.3.1 Global Bioengineered Protein Drugs Sales Forecast by Type (2018-2023) 13.3.2 Global Bioengineered Protein Drugs Revenue Forecast by Type (2018-2023) 13.3.3 Global Bioengineered Protein Drugs Price Forecast by Type (2018-2023) 13.4 Global Bioengineered Protein Drugs Sales Volume Forecast by Application (2018-2023) 13.4.1 Global Bioengineered Protein Drugs Sales Forecast by Application (2018-2023) 13.4.2 Global Bioengineered Protein Drugs Market Share Forecast by Application (2018-2023) 14 Sales Channel, Distributors, Traders and Dealers 14.1 Sales Channel 14.1.1 Direct Marketing 14.1.2 Indirect Marketing 14.1.3 Marketing Channel Future Trend 14.2 Distributors, Traders and Dealers 15 Research Findings and Conclusion 16 Appendix 16.1 Methodology/Research Approach 16.2 Analyst Introduction 16.3 Data Source

List of Tables and Figures Figure Bioengineered Protein Drugs Picture Table Product Specifications of Bioengineered Protein Drugs Figure Global Sales Market Share of Bioengineered Protein Drugs by Types in 2017 Table Bioengineered Protein Drugs Types for Major Manufacturers Figure Therapeutic Proteins Picture Figure Monoclonal Antibodies Picture Figure Vaccines Picture Figure Bioengineered Protein Drugs Sales Market Share by Applications in 2017 Figure Diabetes and Hormonal Disorders Picture Figure Genetic and Fertility Disorders Picture Figure Cancers Picture Figure Organ Transplants Picture Figure Others Picture Figure New Project SWOT Analysis of Bioengineered Protein Drugs Table Industry News List of Bioengineered Protein Drugs Figure Industry Chain Structure of Bioengineered Protein Drugs Table Raw Material Suppliers and Price Analysis Figure Global Raw Material A Price Trend (USD/MT) Figure Global Raw Material B Price Trend (USD/MT) Figure Global Raw Material C Price Trend (USD/MT) Table Manufacturing Cost Structure Analysis of Bioengineered Protein Drugs in 2017 Figure Manufacturing Process Analysis of Bioengineered Protein Drugs Table Raw Materials Sources of Bioengineered Protein Drugs Major Manufacturers in 2017 Table Major Buyers of Bioengineered Protein Drugs Table Abbott Laboratories Basic Information List Table Abbott Laboratories Bioengineered Protein Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure Abbott Laboratories Bioengineered Protein Drugs Sales Growth Rate (2012-2017) Figure Abbott Laboratories Bioengineered Protein Drugs Sales Global Market Share (%) (2012-2017) Figure Abbott Laboratories Bioengineered Protein Drugs Revenue Global Market Share (%) (2012-2017) Table Therapeutic Proteins Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Monoclonal Antibodies Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Vaccines Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Abbott Laboratories Bioengineered Protein Drugs Volume in Diabetes and Hormonal Disorders and Its Application Share Table Abbott Laboratories Bioengineered Protein Drugs Volume in Genetic and Fertility Disorders and Its Application Share Table Abbott Laboratories Bioengineered Protein Drugs Volume in Cancers and Its Application Share Table F. Hoffmann-La Roche Ltd Basic Information List Table F. Hoffmann-La Roche Ltd Bioengineered Protein Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure F. Hoffmann-La Roche Ltd Bioengineered Protein Drugs Sales Growth Rate (2012-2017) Figure F. Hoffmann-La Roche Ltd Bioengineered Protein Drugs Sales Global Market Share (%) (2012-2017) Figure F. Hoffmann-La Roche Ltd Bioengineered Protein Drugs Revenue Global Market Share (%) (2012-2017) Table Therapeutic Proteins Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Monoclonal Antibodies Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Vaccines Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table F. Hoffmann-La Roche Ltd Bioengineered Protein Drugs Volume in Diabetes and Hormonal Disorders and Its Application Share Table F. Hoffmann-La Roche Ltd Bioengineered Protein Drugs Volume in Genetic and Fertility Disorders and Its Application Share Table F. Hoffmann-La Roche Ltd Bioengineered Protein Drugs Volume in Cancers and Its Application Share Table Amgen, Inc. Basic Information List Table Amgen, Inc. Bioengineered Protein Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure Amgen, Inc. Bioengineered Protein Drugs Sales Growth Rate (2012-2017) Figure Amgen, Inc. Bioengineered Protein Drugs Sales Global Market Share (%) (2012-2017) Figure Amgen, Inc. Bioengineered Protein Drugs Revenue Global Market Share (%) (2012-2017) Table Therapeutic Proteins Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Monoclonal Antibodies Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Vaccines Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Amgen, Inc. Bioengineered Protein Drugs Volume in Diabetes and Hormonal Disorders and Its Application Share Table Amgen, Inc. Bioengineered Protein Drugs Volume in Genetic and Fertility Disorders and Its Application Share Table Amgen, Inc. Bioengineered Protein Drugs Volume in Cancers and Its Application Share Table Bayer AG Basic Information List Table Bayer AG Bioengineered Protein Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure Bayer AG Bioengineered Protein Drugs Sales Growth Rate (2012-2017) Figure Bayer AG Bioengineered Protein Drugs Sales Global Market Share (%) (2012-2017) Figure Bayer AG Bioengineered Protein Drugs Revenue Global Market Share (%) (2012-2017) Table Therapeutic Proteins Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Monoclonal Antibodies Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Vaccines Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Bayer AG Bioengineered Protein Drugs Volume in Diabetes and Hormonal Disorders and Its Application Share Table Bayer AG Bioengineered Protein Drugs Volume in Genetic and Fertility Disorders and Its Application Share Table Bayer AG Bioengineered Protein Drugs Volume in Cancers and Its Application Share Table Merck & Co., Inc. Basic Information List Table Merck & Co., Inc. Bioengineered Protein Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure Merck & Co., Inc. Bioengineered Protein Drugs Sales Growth Rate (2012-2017) Figure Merck & Co., Inc. Bioengineered Protein Drugs Sales Global Market Share (%) (2012-2017) Figure Merck & Co., Inc. Bioengineered Protein Drugs Revenue Global Market Share (%) (2012-2017) Table Therapeutic Proteins Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Monoclonal Antibodies Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Vaccines Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Merck & Co., Inc. Bioengineered Protein Drugs Volume in Diabetes and Hormonal Disorders and Its Application Share Table Merck & Co., Inc. Bioengineered Protein Drugs Volume in Genetic and Fertility Disorders and Its Application Share Table Merck & Co., Inc. Bioengineered Protein Drugs Volume in Cancers and Its Application Share Table Dr. Reddy's Laboratories Ltd. Basic Information List Table Dr. Reddy's Laboratories Ltd. Bioengineered Protein Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure Dr. Reddy's Laboratories Ltd. Bioengineered Protein Drugs Sales Growth Rate (2012-2017) Figure Dr. Reddy's Laboratories Ltd. Bioengineered Protein Drugs Sales Global Market Share (%) (2012-2017) Figure Dr. Reddy's Laboratories Ltd. Bioengineered Protein Drugs Revenue Global Market Share (%) (2012-2017) Table Therapeutic Proteins Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Monoclonal Antibodies Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Vaccines Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Dr. Reddy's Laboratories Ltd. Bioengineered Protein Drugs Volume in Diabetes and Hormonal Disorders and Its Application Share Table Dr. Reddy's Laboratories Ltd. Bioengineered Protein Drugs Volume in Genetic and Fertility Disorders and Its Application Share Table Dr. Reddy's Laboratories Ltd. Bioengineered Protein Drugs Volume in Cancers and Its Application Share Table Biocon Ltd. Basic Information List Table Biocon Ltd. Bioengineered Protein Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure Biocon Ltd. Bioengineered Protein Drugs Sales Growth Rate (2012-2017) Figure Biocon Ltd. Bioengineered Protein Drugs Sales Global Market Share (%) (2012-2017) Figure Biocon Ltd. Bioengineered Protein Drugs Revenue Global Market Share (%) (2012-2017) Table Therapeutic Proteins Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Monoclonal Antibodies Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Vaccines Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Biocon Ltd. Bioengineered Protein Drugs Volume in Diabetes and Hormonal Disorders and Its Application Share Table Biocon Ltd. Bioengineered Protein Drugs Volume in Genetic and Fertility Disorders and Its Application Share Table Biocon Ltd. Bioengineered Protein Drugs Volume in Cancers and Its Application Share Table Eli Lilly and Company Basic Information List Table Eli Lilly and Company Bioengineered Protein Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure Eli Lilly and Company Bioengineered Protein Drugs Sales Growth Rate (2012-2017) Figure Eli Lilly and Company Bioengineered Protein Drugs Sales Global Market Share (%) (2012-2017) Figure Eli Lilly and Company Bioengineered Protein Drugs Revenue Global Market Share (%) (2012-2017) Table Therapeutic Proteins Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Monoclonal Antibodies Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Vaccines Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Eli Lilly and Company Bioengineered Protein Drugs Volume in Diabetes and Hormonal Disorders and Its Application Share Table Eli Lilly and Company Bioengineered Protein Drugs Volume in Genetic and Fertility Disorders and Its Application Share Table Eli Lilly and Company Bioengineered Protein Drugs Volume in Cancers and Its Application Share Table Sanofi Basic Information List Table Sanofi Bioengineered Protein Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure Sanofi Bioengineered Protein Drugs Sales Growth Rate (2012-2017) Figure Sanofi Bioengineered Protein Drugs Sales Global Market Share (%) (2012-2017) Figure Sanofi Bioengineered Protein Drugs Revenue Global Market Share (%) (2012-2017) Table Therapeutic Proteins Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Monoclonal Antibodies Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Vaccines Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Sanofi Bioengineered Protein Drugs Volume in Diabetes and Hormonal Disorders and Its Application Share Table Sanofi Bioengineered Protein Drugs Volume in Genetic and Fertility Disorders and Its Application Share Table Sanofi Bioengineered Protein Drugs Volume in Cancers and Its Application Share Table GlaxoSmithKline plc Basic Information List Table GlaxoSmithKline plc Bioengineered Protein Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure GlaxoSmithKline plc Bioengineered Protein Drugs Sales Growth Rate (2012-2017) Figure GlaxoSmithKline plc Bioengineered Protein Drugs Sales Global Market Share (%) (2012-2017) Figure GlaxoSmithKline plc Bioengineered Protein Drugs Revenue Global Market Share (%) (2012-2017) Table Therapeutic Proteins Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Monoclonal Antibodies Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Vaccines Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table GlaxoSmithKline plc Bioengineered Protein Drugs Volume in Diabetes and Hormonal Disorders and Its Application Share Table GlaxoSmithKline plc Bioengineered Protein Drugs Volume in Genetic and Fertility Disorders and Its Application Share Table GlaxoSmithKline plc Bioengineered Protein Drugs Volume in Cancers and Its Application Share Table Global Bioengineered Protein Drugs Sales by Manufacturer (2016-2017) Figure Global Bioengineered Protein Drugs Sales Market Share by Manufacturer in 2016 Figure Global Bioengineered Protein Drugs Sales Market Share by Manufacturer in 2017 Table Global Bioengineered Protein Drugs Revenue by Manufacturer (2016-2017) Figure Global Bioengineered Protein Drugs Revenue Market Share by Manufacturer in 2016 Figure Global Bioengineered Protein Drugs Revenue Market Share by Manufacturer in 2017 Figure Top 3 Bioengineered Protein Drugs Manufacturer (Revenue) Market Share in 2017 Figure Top 6 Bioengineered Protein Drugs Manufacturer (Revenue) Market Share in 2017 Figure Global Bioengineered Protein Drugs Sales and Growth Rate (2012-2017) Figure Global Bioengineered Protein Drugs Revenue and Growth Rate (2012-2017) Table Global Bioengineered Protein Drugs Sales by Regions (2012-2017) Table Global Bioengineered Protein Drugs Sales Market Share by Regions (2012-2017) Table Global Bioengineered Protein Drugs Revenue by Regions (2012-2017) Table Global Bioengineered Protein Drugs Revenue Market Share by Regions in 2012 Table Global Bioengineered Protein Drugs Revenue Market Share by Regions in 2017 Figure North America Bioengineered Protein Drugs Sales and Growth Rate (2012-2017) Figure Europe Bioengineered Protein Drugs Sales and Growth Rate (2012-2017) Figure Asia-Pacific Bioengineered Protein Drugs Sales and Growth Rate (2012-2017) Figure South America Bioengineered Protein Drugs Sales and Growth Rate (2012-2017) Figure Middle East and Africa Bioengineered Protein Drugs Sales and Growth Rate (2012-2017) Figure North America Bioengineered Protein Drugs Revenue and Growth Rate (2012-2017) Table North America Bioengineered Protein Drugs Sales by Countries (2012-2017) Table North America Bioengineered Protein Drugs Sales Market Share by Countries (2012-2017) Figure North America Bioengineered Protein Drugs Sales Market Share by Countries in 2012 Figure North America Bioengineered Protein Drugs Sales Market Share by Countries in 2017 Table North America Bioengineered Protein Drugs Revenue by Countries (2012-2017) Table North America Bioengineered Protein Drugs Revenue Market Share by Countries (2012-2017) Figure North America Bioengineered Protein Drugs Revenue Market Share by Countries in 2012 Figure North America Bioengineered Protein Drugs Revenue Market Share by Countries in 2017 Figure United States Bioengineered Protein Drugs Sales and Growth Rate (2012-2017) Figure Canada Bioengineered Protein Drugs Sales and Growth Rate (2012-2017) Figure Mexico Bioengineered Protein Drugs Sales and Growth Rate (2012-2017) Figure Europe Bioengineered Protein Drugs Revenue and Growth Rate (2012-2017) Table Europe Bioengineered Protein Drugs Sales by Countries (2012-2017) Table Europe Bioengineered Protein Drugs Sales Market Share by Countries (2012-2017) Table Europe Bioengineered Protein Drugs Revenue by Countries (2012-2017) Table Europe Bioengineered Protein Drugs Revenue Market Share by Countries in 2012 Table Europe Bioengineered Protein Drugs Revenue Market Share by Countries in 2017 Figure Germany Bioengineered Protein Drugs Sales and Growth Rate (2012-2017) Figure UK Bioengineered Protein Drugs Sales and Growth Rate (2012-2017) Figure France Bioengineered Protein Drugs Sales and Growth Rate (2012-2017) Figure Russia Bioengineered Protein Drugs Sales and Growth Rate (2012-2017) Figure Italy Bioengineered Protein Drugs Sales and Growth Rate (2012-2017) Figure Asia-Pacific Bioengineered Protein Drugs Revenue and Growth Rate (2012-2017) Table Asia-Pacific Bioengineered Protein Drugs Sales by Countries (2012-2017) Table Asia-Pacific Bioengineered Protein Drugs Sales Market Share by Countries (2012-2017) Table Asia-Pacific Bioengineered Protein Drugs Sales Market Share by Countries (2012-2017) Table Asia-Pacific Bioengineered Protein Drugs Revenue by Countries (2012-2017) Table Asia-Pacific Bioengineered Protein Drugs Revenue Market Share by Countries (2012-2017) Figure China Bioengineered Protein Drugs Sales and Growth Rate (2012-2017) Figure Japan Bioengineered Protein Drugs Sales and Growth Rate (2012-2017) Figure Korea Bioengineered Protein Drugs Sales and Growth Rate (2012-2017) Figure India Bioengineered Protein Drugs Sales and Growth Rate (2012-2017) Figure Southeast Asia Bioengineered Protein Drugs Sales and Growth Rate (2012-2017) Figure South America Bioengineered Protein Drugs Revenue and Growth Rate (2012-2017) Table South America Bioengineered Protein Drugs Sales by Countries (2012-2017) Table South America Bioengineered Protein Drugs Sales Market Share by Countries (2012-2017) Figure South America Bioengineered Protein Drugs Sales Market Share by Countries in 2017 Table South America Bioengineered Protein Drugs Revenue by Countries (2012-2017) Table South America Bioengineered Protein Drugs Revenue Market Share by Countries (2012-2017) Figure South America Bioengineered Protein Drugs Revenue Market Share by Countries in 2017 Figure Brazil Bioengineered Protein Drugs Sales and Growth Rate (2012-2017) Figure Argentina Bioengineered Protein Drugs Sales and Growth Rate (2012-2017) Figure Columbia Bioengineered Protein Drugs Sales and Growth Rate (2012-2017) Figure Middle East and Africa Bioengineered Protein Drugs Revenue and Growth Rate (2012-2017) Table Middle East and Africa Bioengineered Protein Drugs Sales by Countries (2012-2017) Table Middle East and Africa Bioengineered Protein Drugs Sales Market Share by Countries (2012-2017) Figure Middle East and Africa Bioengineered Protein Drugs Sales Market Share by Countries in 2017 Table Middle East and Africa Bioengineered Protein Drugs Revenue by Countries (2012-2017) Table Middle East and Africa Bioengineered Protein Drugs Revenue Market Share by Countries (2012-2017) Figure Middle East and Africa Bioengineered Protein Drugs Revenue Market Share by Countries in 2012 Figure Middle East and Africa Bioengineered Protein Drugs Revenue Market Share by Countries in 2017 Figure Saudi Arabia Bioengineered Protein Drugs Sales and Growth Rate (2012-2017) Figure UAE Bioengineered Protein Drugs Sales and Growth Rate (2012-2017) Figure Egypt Bioengineered Protein Drugs Sales and Growth Rate (2012-2017) Figure Nigeria Bioengineered Protein Drugs Sales and Growth Rate (2012-2017) Figure South Africa Bioengineered Protein Drugs Sales and Growth Rate (2012-2017) Table Global Bioengineered Protein Drugs Sales by Type (2012-2017) Table Global Bioengineered Protein Drugs Sales Share by Type (2012-2017) Table Global Bioengineered Protein Drugs Revenue by Type (2012-2017) Table Global Bioengineered Protein Drugs Revenue Share by Type (2012-2017) Figure Global Therapeutic Proteins Sales Growth Rate (2012-2017) Figure Global Therapeutic Proteins Sales Price (2012-2018) Figure Global Therapeutic Proteins Sales Growth Rate (2012-2017) Figure Global Monoclonal Antibodies Sales Price (2012-2018) Figure Global Vaccines Sales Growth Rate (2012-2017) Figure Global Vaccines Sales Price (2012-2018) Table Global Bioengineered Protein Drugs Sales by Application (2012-2017) Table Global Bioengineered Protein Drugs Sales Share by Application (2012-2017) Figure Global Diabetes and Hormonal Disorders Sales Growth Rate (2012-2017) Figure Global Genetic and Fertility Disorders Sales Growth Rate (2012-2017) Figure Global Cancers Sales Growth Rate (2012-2019) Figure Global Organ Transplants Sales Growth Rate (2012-2020) Figure Global Others Sales Growth Rate (2012-2021) Figure Global Bioengineered Protein Drugs Sales, Revenue and Growth Rate (2018-2023) Table Global Bioengineered Protein Drugs Sales Forecast by Regions (2018-2023) Table Global Bioengineered Protein Drugs Market Share Forecast by Regions (2018-2023) Figure North America Sales Bioengineered Protein Drugs Market Forecast (2018-2023) Figure Europe Sales Bioengineered Protein Drugs Market Forecast (2018-2023) Figure Asia-Pacific Sales Bioengineered Protein Drugs Market Forecast (2018-2023) Figure South America Sales Bioengineered Protein Drugs Market Forecast (2018-2023) Figure Middle East and Africa Sales Bioengineered Protein Drugs Market Forecast (2018-2023) Table Global Bioengineered Protein Drugs Sales Forecast by Type (2018-2023) Table Global Bioengineered Protein Drugs Market Share Forecast by Type (2018-2023) Table Global Bioengineered Protein Drugs Sales Forecast by Application (2018-2023) Table Global Bioengineered Protein Drugs Market Share Forecast by Application (2018-2023) Table Distributors/Traders/ Dealers List

Abbott Laboratories F. Hoffmann-La Roche Ltd Amgen, Inc. Bayer AG Merck & Co., Inc. Dr. Reddy's Laboratories Ltd. Biocon Ltd. Eli Lilly and Company Sanofi GlaxoSmithKline plc Johnson & Johnson JanssenNovartis AG Panacea Biotec ProBioGen AG